Targeted Antimicrobial Agent Prophylaxis Fails to Reduce Peristomal Infections by Multi-Drug-Resistant Bacteria Following Percutaneous Endoscopic Gastrostomy: A Prospective Cohort Study
Surgical Infections · 01.10.2026 · 27 (8) · 552-559
DOI: 10.1177/10962964261438723 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Surgical Infections, online erschienen am 23.04.2026. Verfasst von Blanca Marzo-Escartín und 9 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department. Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campu…. Hauptthemen laut MEDLINE: Antibiotic Prophylaxis, Gastrostomy, Drug Resistance, Multiple, Bacterial, Surgical Wound Infection. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Peristomal infection (PI) is the most frequent complication following percutaneous gastrostomy, and the increase of multi-drug-resistant (MDR) bacteria poses a therapeutic challenge. We evaluated whether targeted antimicrobial agent prophylaxis (TAP), on the basis of pre-procedure rectal screening, reduces the incidence of MDR PIs compared with standard prophylaxis.
Methods
We conducted a single-center, single-arm, open-label trial, comparing a prospective cohort (July 2021–July 2022) receiving TAP based on MDR screening results with a retrospective cohort (June 2020–June 2021) that received standard prophylaxis. A total of 118 patients were included, 60 in the intervention group and 58 in the historical cohort. TAP patients underwent a pre-procedure screening tactic, using nasal, axillary, inguinal, pharyngo-tonsillar, and rectal swabs. Patients with positive cultures received prophylaxis with an antibiotic agent active against the isolated bacteria, along with coverage for methicillin-sensitive Staphylococcus aureus . Patients with negative cultures received standard prophylaxis with amoxicillin–clavulanate. Both regimens were administered as a single dose one hour before the procedure.
Results
MDR colonization was detected in 36.4% of screened patients. The 30-day PI incidence was comparable in both cohorts [20.7% (12/58) in the historical cohort vs. 16.7% (10/60) in the intervention group; p = 0.64]. Among TAP patients who developed PI, 7/10 had negative MDR screening, 3/10 had infections caused by pathogens different from those identified in screening, and 2/10 developed infections with the same MDR bacteria despite appropriate prophylaxis.
Conclusions
In patients undergoing percutaneous gastrostomy, TAP based on MDR colonization status did not reduce the incidence of PIs or MDR etiology compared with standard prophylaxis. Our findings question the role of colonization-guided prophylaxis in percutaneous gastrostomy and underscore the need for alternative preventive tactics in surgical site infection control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Department. Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Nutritional Support Unit, Endocrinology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Microbiology Department. Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Endoscopy Unit, Digestive System Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Interventional Vascular Radiology Unit, Radiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Ester Márquez-Algaba
Zitieren
APA
Marzo-Escartín, B., Villamarín-Melio, M., Márquez-Algaba, E., Palmas-Candía, F. X., Zabalegui, A., Burgos-Peláez, R., Lung-Suárez, M., Dot, J., Pérez-Lafuente, M., & Len, Ó. (2026). Targeted Antimicrobial Agent Prophylaxis Fails to Reduce Peristomal Infections by Multi-Drug-Resistant Bacteria Following Percutaneous Endoscopic Gastrostomy: A Prospective Cohort Study. Surgical Infections, 27(8), 552-559. https://doi.org/10.1177/10962964261438723
Vancouver
Marzo-Escartín B, Villamarín-Melio M, Márquez-Algaba E, Palmas-Candía FX, Zabalegui A, Burgos-Peláez R, et al. Targeted Antimicrobial Agent Prophylaxis Fails to Reduce Peristomal Infections by Multi-Drug-Resistant Bacteria Following Percutaneous Endoscopic Gastrostomy: A Prospective Cohort Study. Surgical Infections. 2026;27(8):552-559. doi:10.1177/10962964261438723
BibTeX
@article{MarzoEscartn2026,
author = {Marzo-Escartín, Blanca and Villamarín-Melio, Miguel and Márquez-Algaba, Ester and Palmas-Candía, Fiorella Ximena and Zabalegui, Alba and Burgos-Peláez, Rosa and Lung-Suárez, Mayli and Dot, Joan and Pérez-Lafuente, Mercedes and Len, Óscar},
title = {Targeted Antimicrobial Agent Prophylaxis Fails to Reduce Peristomal Infections by Multi-Drug-Resistant Bacteria Following Percutaneous Endoscopic Gastrostomy: A Prospective Cohort Study},
journal = {Surgical Infections},
year = {2026},
volume = {27},
number = {8},
pages = {552--559},
doi = {10.1177/10962964261438723}
}
EUVIMED